Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CVS HEALTH Corp Director's Dealing 2007

Jun 12, 2007

29875_dirs_2007-06-12_65902089-fbe9-4ebb-b9d4-224814223b25.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS CAREMARK CORP (CVS)
CIK: 0000064803
Period of Report: 2007-06-11

Reporting Person: WILLIAMS KRISTEN GIBNEY (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2007-06-11 Common Stock M 33739 $20.23 Acquired 80486 Direct
2007-06-11 Common Stock S 360 $37.46 Disposed 80126 Direct
2007-06-11 Common Stock S 1350 $37.47 Disposed 78776 Direct
2007-06-11 Common Stock S 8350 $37.48 Disposed 70426 Direct
2007-06-11 Common Stock S 600 $37.49 Disposed 69826 Direct
2007-06-11 Common Stock S 6800 $37.5 Disposed 63026 Direct
2007-06-11 Common Stock S 3074 $37.51 Disposed 59952 Direct
2007-06-11 Common Stock S 1099 $37.52 Disposed 58853 Direct
2007-06-11 Common Stock S 5306 $37.53 Disposed 53547 Direct
2007-06-11 Common Stock S 2500 $37.54 Disposed 51047 Direct
2007-06-11 Common Stock S 2737 $37.55 Disposed 48310 Direct
2007-06-11 Common Stock S 1563 $37.56 Disposed 46747 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2007-06-11 Stock Option $20.23 M 33739 Disposed 2015-03-01 Common Stock (33739) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option $9.17 2013-02-25 Common Stock (46849) 46849 Direct
Stock Option $13.41 2014-01-02 Common Stock (46856) 46856 Direct
Stock Option $27.12 2016-03-01 Common Stock (33726) 33726 Direct

Footnotes

F1: Option acquired in connection with the merger of Caremark Rx, Inc. with a subsidiary of CVS Corporation and the conversion of Caremark Rx, Inc. stock option to CVS/Caremark Corporation stock option. Option is 100% exercisable as of the date of the merger.